David Cork

Join us May 20 in Carlsbad or via our live virtual stream! This CME conference will offer a comprehensive summary of new medications and clinical data pertaining to the management and treatment of atherosclerosis. Register now: bit.ly/41V7zve

Proud to share our @JACCJournals paper on benefits of RV-only >> BiV pacing in #LVAD pts. Bottom line: if your LVAD pts have CRT-D, turn off LV pacing! @NirUrielMD @JonGrinsteinMD @AnnNguyenMD @Nikhil15 @LuiseHolzhauser @gtsayer @BurkhoffMd @robertomlang sciencedirect.com/science/articl…

Excited to promote our inaugural atherosclerosis conference. scripps.org/events/cardiov…

The @US_FDA should require a postmarketing trial of high-dose icosapent ethyl (#Vascepa) vs corn oil in patients at risk for CV events to resolve the conflicting findings of the #STRENGTHTrial & #REDUCEIT trials on the potential health benefits of omega-3s ja.ma/39Ssuax

via ⁦@nytopinion⁩ nytimes.com/2020/05/29/opi…

@AdamMikMD @UICDom Congrats!

Beyond excited for this new opportunity to help mentor our amazing residents! Thank you @UICDom!

I too hope this is a moment of ethical reckoning for health disparities in our country. Poignant words by the always thoughtful @NMHheartdoc on the effects of #COVID19 in African American communities ja.ma/2yeR4BQ

Interesting commentary and interview on how COVID patients differ from patients with typical ARDS

In my 7 days on one of our (now 12!) non ICU #COVID19 units, I admitted 58 patients for COVID rule out, of whom 50 tested positive. Two died (DNR), 2 went to hospice, and 5 went to the ICU. That is… not my typical gen med service week. Following, some clinical observations.